New Drug Treatment for Diabetes to Reduce Kidney and Cardiovascular Risk
Links shared publicly online about this topic
Mixed Results From ACCORD: Study Found No Overall Reduction In Cardiovascular Risk, But Benefits To Eyes, Kidneys And Nerves
medicalnewstoday.com — “Five-year results of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study confirm that neither more intensive lowering of blood glucose (sugar) levels, more intensive lowering of b” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2010 at 11:27 am By:
MedicalNewsToday: Mixed Results From ACCORD: Study Found No Overall Reduction In: http://bit.ly/cPxFxq Full http://bit.ly/cHvU77
Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk - Drugs.com MedNews
drugs.com — “Intensive control of blood glucose levels does not reduce the odds of cardiovascular disease for those with long-term type 2 diabetes who are at risk of heart p” View full resource at drugs.com
Most Recently Shared on June 29, 2010 at 10:03 pm By:
Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk - http://bit.ly/bqPr66
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial : The Lancet
thelancet.com — “Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. By - Prof Dick de Zeeuw MD, Pro...” View full resource at thelancet.com
Most Recently Shared on November 4, 2010 at 10:11 am By:
Lancet study showing new use of drug to lower kidney-related and cardiovascular risk in diabetics http://bit.ly/dhpNfL #TheLancet
Medical News: Serious Side Effects Seen with Novel Nephropathy Drug - in Nephrology, Diabetes from MedPage Today
medpagetoday.com — “Added to standard treatment, avosentan, an investigational endothelin antagonist, reduced albuminuria but heightened the risk of cardiovascular problems in patients with overt diabetic nephropathy, a” View full resource at medpagetoday.com
Most Recently Shared on February 19, 2010 at 3:42 pm By:
Serious Side Effects Seen with Novel Nephropathy Drug (CME/CE) Added to standard treatment, avosentan, an investigati.. http://bit.ly/bQ01qw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
Advertisement
